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Human herpesvirus-8 K8.1 gene encodes for two immunogenic class I glycoproteins, K8.1A and B, originating from spliced
messages [(1998) Virology 243, 208–217]. The 228-amino-acid-long K8.1A open reading frame (ORF) contains four N-
glycosylation sites and the 167-amino-acid-long K8.1B ORF contains three N-glycosylation sites, sharing similar amino- and
carboxyl-termini with ORF K8.1A but with an in-frame deletion [(1998) Virology 249, 140–149]. To characterize the K8.1A and
B glycoproteins in the infected body cavity-based B cell lymphoma (BCBL-1) cells and in the virion envelopes, monoclonal
antibodies (MAbs) recognizing only K8.1A protein or both K8.1A and B proteins were generated. These antibodies reacted
with the infected cell membranes and virion envelopes. Stable COS-1 transformant cells expressed the K8.1A and B proteins
independently on the plasma membranes. MAbs recognized multiple proteins with molecular weights ranging from 23 to 72
kDa from the BCBL-1 cells and COS-1 cells and the 72 to 68 kDa molecular-weight proteins from the virion particles. The
K8.1A is the predominant protein affinity purified from the infected BCBL-1 cells. Digestion with glycosidases show that these
proteins contain both N- and O-linked sugars, suggesting that the multiple proteins recognized by the MAbs represent the
precursor and product forms of K8.1A and B proteins, and the 72 to 68 kDa molecular-weight proteins represent the virion
particle-associated mature forms of these glycoproteins. © 1999 Academic Press
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tINTRODUCTION
Human herpesvirus-8 (HHV-8) or Kaposi’s sarcoma-
ssociated herpesvirus (KSHV) is associated with ac-
uired immune deficiency syndrome (AIDS)-KS and non-
IDS KS. HHV-8 DNA has been detected in more than
5% of Kaposi’s lesions in all clinical subtypes of KS
Chang et al., 1994; Schulz et al., 1998). HHV-8 sequences
ave been also detected in primary effusion lymphomas
r body cavity-based B cell lymphomas (BCBLs) (Cesar-
an et al., 1995a,b; Moore et al., 1996). BCBL-1 and BC-3
ells carry only HHV-8, and a lytic cycle can be induced
y phorbol ester-TPA (Renne et al., 1996; Zhong et al.,
996). HHV-8 DNA is about 160 kb, encoding 80 complete
pen reading frames (ORFs), and the gene arrangements
nd protein sequences deduced from these sequences
how close similarity to the members of g-herpesvirus
roup (Russo et al., 1996; Neipel, 1997). These HHV-8
RFs are currently identified as ORFs 1–75 by their
imilarity to herpesvirus saimiri ORFs. Russo et al. (1996)
lso identified 15 ORFs unique for HHV-8 designated
1–K15. Neipel et al. (1997) identified four additional
HV-8 unique ORFs and assigned decimal K numbers
or them (K4.1, K4.2, K8.1, and K10.1).
Herpesviruses encode at least 5–10 virion envelope-
ssociated glycoproteins, and these glycoproteins are
rucial to the viral replication cycle (Kieff, 1996; Spear,
1 To whom reprint requests should be addressed at 3901 Rainbow
flvd. Fax: (913) 588-7295. E-mail: bchandra@kumc.edu.
237993). They mediate several functions in the interaction
etween virus and host cells such as the attachment to
ellular receptors, fusion of membranes, and egress
rom the cell. Importantly, many of these envelope glyco-
roteins serve as major targets for the host immune
ystem. Sequencing data show that HHV-8 has counter-
arts to other herpesvirus glycoproteins gB, gH, and gL.
n addition to these conserved glycoproteins, HHV-8
enes K1 and K8.1 encode for glycoproteins unique for
HV-8 (Lee et al., 1998; Neipal et al., 1997; Russo et al.,
996). Knowledge about HHV-8 glycoproteins is limited.
n our studies, human sera recognized several HHV-8
lycoproteins with molecular weights ranging from 29 to
28 kDa from uninduced and 12-O-tetradecanoylphorbol-
3-acetate (TPA)-induced BCBL-1 cells (Chandran et al.,
998a). We have initially identified cDNAs originating
rom the HHV-8 K8.1 gene, which encoded two ORFs
enerated from spliced messages (Chandran et al.,
998a). One cDNA encodes for a 228-amino-acid protein
esignated K8.1A with a cleavable signal sequence, a
ransmembrane domain, and four N-glycosylation sites.
he splicing event has generated the transmembrane
omain in the K8.1A ORF not seen in the genomic K8.1
RF. Another cDNA encodes for an ORF of 167 amino
cids designated K8.1B with three N-glycosylation sites,
haring similar amino- and carboxyl-termini with ORF
8.1A but with an in-frame deletion (Chandran et al.,
998b). K8.1A and B ORFs possess several serine and
hreonine residues (.20), which are the potential sites
or O-glycosylation. In the presence of microsomal mem-
0042-6822/99 $30.00
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238 ZHU, PURI, AND CHANDRANranes, the primary translation products of ORF K8.1A 34
Da and ORF K8.1B 20 kDa in the in vitro transcription/
ranslation experiments shifted into glycosylated species
f 43 and 32 kDa, respectively (Chandran et al., 1998b).
his suggested that the ORFs K8.1A and B encode for
lycoproteins. Riboprobes from the K8.1A cDNA insert
ybridized with a HHV-8-specific 0.9-kb abundant tran-
cript from the BCBL-1 cells. Synthesis of this RNA was
liminated in the presence of a DNA synthesis inhibitor,
uggesting that this RNA was a late gene transcript
Chandran et al., 1998b). Our studies with human sera
lso demonstrated the immunogenic nature of K8.1A/B
lycoproteins (Chandran et al., 1998b; Zhu et al., 1999).
Rabb et al. (1998) suggested that the glycoproteins
p35kDa–37kDa in the BCBL cells were encoded by the
8.1 ORF. While the current work was in progress, the
se of polyclonal rabbit antibodies against the genomic
RF K8.1 protein (amino acids 26–142). Li et al. (1999)
dentified the K8.1 protein as a virion envelope-associ-
ted glycoprotein. However, the identity of the K8.1A/B
lycoproteins in the infected cells and the virion enve-
ope was not defined. To characterize the K8.1A/B glyco-
roteins, we expressed the K8.1A and B proteins in the
nsect cells and in the COS-1 cells and developed MAbs
gainst the baculovirus-expressed proteins. These anti-
odies were used in the identification and characteriza-
ion of these glycoproteins in the infected BCBL-1 cells
nd in the transfected COS-1 cells. Our studies show that
hese glycoproteins are associated with the virion enve-
opes and the surfaces of BCBL-1 and COS-1 cells. MAbs
ecognized multiple proteins with molecular weights
anging from 23 to 72 kDa from the BCBL-1 and COS-1
ells and the proteins of 68 to 72 kDa from the virion
FIG. 1. Reactivities of K8.1A and K8.1A/B MAbs in the Western blot r
ORFs were subcloned from the cDNAs (Chandran et al., 1998a,b). The
ells and purified by glutathione–Sepharose columns (Zhu et al., 1999).
ere run on 12% acrylamide gel, Western blotted, and reacted with th
anes; the numbers on the right indicate the molecular masses in kDa.
rotein. Lanes 1 and 2, Coomassie stain of the gel. Lanes 3 and 4, rea
anes 7 and 8, reactivities of K8.1A MAb 3B5. Lanes 9 and 10, reactivarticles. The K8.1A form is the predominant protein Gffinity purified from the infected BCBL-1 cells. Digestion
ith glycosidases shows that these proteins contain
oth N- and O-linked sugars, suggesting that the multiple
roteins recognized by the MAbs represent the precur-
or and product forms of K8.1A and B proteins and the
roteins of 68–72 kDa represent the virion particle-asso-
iated mature forms of these glycoproteins.
RESULTS
Abs against K8.1A/B proteins show differential
eactivities
GST-K8.1A and -K8.1B proteins expressed in the insect
ells were purified by glutathione–Sepharose 4B. The
urity of these proteins was verified by SDS–PAGE fol-
owed by staining with Coomassie blue (Fig. 1, lanes 1
nd 2) or with BioRad zinc stain kit (data not shown). The
urified GST protein was about 29 kDa, and the observed
izes of K8.1A and B fusion proteins were 62 and 54 kDa,
espectively (Fig. 1, lanes 1 and 2). Purified GST-K8.1A
nd -K8.1B fusion proteins were recognized by the rabbit
nti-peptide antibodies (Chandran et al., 1998b) recog-
izing both K8.1A and B proteins (data not shown). These
roteins were used to immunize the mice. Mice were
led by tail vein, and dilutions of sera were tested in the
estern blot reactions with the K8.1A and B proteins.
pleen from a mouse with the highest level of antibodies
as used for fusion.
Hybridoma culture supernatants were screened by
mmunofluorescence assay (IFA) with TPA-induced
CBL-1 and BJAB cells, by ELISA with TPA-induced
CBL-1 and BJAB cells (Chan et al., 1998), and by West-
rn blot reactions with the GST-K8.1A, GST-K8.1B, and
s with the affinity-purified K8.1A and B proteins. Full-length K8.1A and
re expressed as GST fusion proteins in the baculovirus-infected insect
oncentrations of the purified GST- K8.1A, GST-K8.1B, and GST proteins
ent MAbs. Prestained molecular weight markers were run in parallel
1, 3, 5, 7, and 9, GST-K8.1B protein. Lanes 2, 4, 6, 8, and 10, GST-K8.1A
of K8.1A/B MAb 4A4. Lanes 5 and 6, reactivities of K8.1A/B MAb 6A5.
K8.1A MAb 2A3. No reactivities were detected with the GST protein.eaction
se we
Equal c
e differ
Lanes
ctivitiesST proteins. No reactivity was detected with the GST
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239HHV-8 VIRION ENVELOPE GLYCOPROTEINS K8.1A/Brotein, and specific reactivities with the K8.1A and B
roteins were seen. Thirty-two hybridoma clones secret-
ng antibodies specific for K8.1A/B proteins were identi-
ied and monocloned. Of the 32 clones, 28 clones were
ositive in the Western blot reactions, 25 were positive in
FA, and 29 were positive in ELISA. Several clones reac-
ive in the Western blot reactions and ELISA were neg-
tive in IFA, and vice versa. Because the spleen used for
usion was obtained from a mouse initially immunized
ith TPA-induced BCBl-1 cells and boosted with K8.1A/B
roteins, these differential reactivities demonstrated that
he monoclonal antibodies (MAbs) recognized both con-
ormational and denatured epitopes. Some culture su-
ernatant fluids reacted with both K8.1A and B proteins
K8.1A/B MAbs; Fig. 1, lanes 3–6), whereas others recog-
ized the K8.1A protein only (K8.1A MAbs; Fig. 1, lanes
–10). The characteristics of 10 clones secreting MAbs
ecognizing the K8.1A/B proteins in the Western blot
eactions (linear epitopes) are given in the Table 1. The
dentity of the epitopes recognized by these antibodies
ill be presented elsewhere.
8.1A/B proteins are expressed on the plasma
embranes of the HHV-8-infected BCBL-1 cells
The K8.1A/B or K8.1A MAbs were tested in IFA with
ells permeabilized by acetone fixation. No reactivity
as seen with acetone fixed uninduced and TPA-in-
uced HHV-8-negative BJAB cells or with Epstein–Barr
irus (EBV)-positive P3HR-1 cells (data not shown). About
–2% of uninduced and 10–15% of TPA-induced HHV-8-
TABLE 1
Reactivities of K81.A/B MAbs
Name of
clone Isotype
IFA
(BCBL-1)a
Western blotb
ELISA-
BCBLcBCBL-1 8.1A 8.1B
2A3 IgG2a 1 1 1 2 1
2B6 IgG1 1 1 1 1 1
2D2 IgG1 1 1 1 2 1
3B5 IgG2a 1 1 1 2 1
4A4 IgG1 1 1 1 1 1
4C3 IgG1 1 1 1 2 1
4D6 IgG2a 1 1 1 2 1
5A3 IgG1 1 1 1 2 1
6A5 IgG1 1 1 1 1 1
6C3 IgG2a 1 1 1 2 1
Note. 1; positive reaction by MAbs.
a Reactivities in IFA with the acetone-fixed TPA-induced BCBL-1
ells. No reactivities were detected with the control BJAB cells.
b Reactivities in the Western blot reactions with TPA-induced BCBL-1
ell extracts or with recombinant K8.1A and B glycoproteins affinity
urified from baculovirus-infected insect cells or with K8.1A and K8.1B
lycoproteins expressed in the COS-1 cells.
c Reactivities in ELISA with TPA-induced BCBL-1 cell extracts. No
eactivities were detected with the control BJAB cells.arrying BCBL-1 cells (5 days postinduction) reacted fith the MAbs. These MAbs showed very bright fluores-
ence predominantly localized in the cytoplasm and
lasma membranes (Fig. 2A). Our previous studies
howed that HHV-8-carrying BCBL-1 cells are virus pro-
ucer cells with a certain percentage of cells entering
pontaneously into lytic cycle. About 3% of uninduced
CBL-1 cells showed moderate cytoplasmic fluores-
ence with sera from HIV 1 KS-positive patients and
ith the MAb 11D1 recognizing the HHV-8 early lytic ORF
9 protein and the number of cells recognized by HIV 1
S-positive sera and ORF 59 MAb increased to 15–25%
fter 5 days post-TPA induction (Chandran et al., 1998a;
mith et al., 1997). Similarly, the K8.1A and B MAbs
ecognized about 1–3% of uninduced BCBL-1 cells and
bout 15% of TPA-induced cells. The absence of K8.1A/B
Ab reactivities with the majority of the BCBl-1 cells also
erved as an internal control for the specificity of these
Abs. Our earlier experiments showed that the K8.1
ranscript is a true HHV-8 late gene product requiring
iral DNA replication (Chandran et al., 1998b). The ab-
ence of MAb reactivity with the majority of BCBL-1 cells
atently infected with HHV-8 demonstrated that the MAbs
ecognized proteins from BCBL-1 cells entering lytic cy-
les spontaneously and with cells induced by TPA, most
ikely the lytic cycle HHV-8 K8.1A/B proteins.
To determine whether the K8.1A/B proteins were ex-
ressed on the infected cell plasma membranes, TPA-
nduced BCBL-1 cells (4 days postinduction) were tested
n the surface IFA with the K8.1A and K8.1A/B MAbs and
ith the rabbit anti-K8.1A/B peptide antibodies. No reac-
ivity was observed with uninduced and TPA-induced
JAB cells (data not shown). About 10–15% of the TPA-
nduced BCBL-1 cells showed surface IFA with the anti-
8.1A and anti-K8.1A/B MAbs demonstrating that the
8.1A/B proteins were expressed on the infected cell
lasma membranes (Fig. 2B). Similar reactivities were
bserved with the rabbit anti-peptide antibodies recog-
izing amino acids 140–156 of K8.1A and amino acids
2–97 of K8.1B proteins (Chandran et al., 1998b; data not
hown). These results suggested that the amino-termi-
us of the K8.1A/B protein was exposed to the exterior of
he cells.
8.1A and B proteins are expressed independently on
he plasma membranes of COS-1 cells transfected
ith expression plasmids
For the further characterization of K8.1A and B pro-
eins, COS-1 cells were transfected with the eukaryotic
xpression plasmids containing the K8.1A and B genes,
nd stable transformants were obtained by G418 drug
election. Subsequently, single-cell clones of COS-K8.A
nd COS-K8.1B were established. Cells permeabilized by
cetone fixation were tested in the IFA with the K8.1A/B
r K8.1A MAbs. No reactivity was seen with the acetoneixed control COS-1 cells (data not shown). These MAbs
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240 ZHU, PURI, AND CHANDRANhowed very bright cytoplasmic fluorescence (Figs. 2C
nd 2D), and the K8.1A-specific MAbs reacted only with
he COS-1 cells expressing the K8.1A protein but not with
he cells expressing the K8.1B protein (data not shown).
o determine whether the K8.1 A and K8.1B proteins were
xpressed on the transfected plasma membranes, MAbs
ere tested with the unfixed cells. The anti-K8.1A and
K8.1A/B MAbs showed surface immunofluorescence
ith the transfected COS-1 cells (Figs. 2E and 2F). These
esults demonstrated that the K8.1A and K8.1 B proteins
an be expressed independently on the plasma mem-
ranes. These COS-1-expressed proteins were used for
he further characterization of K8.1A and B proteins.
8.1A/B MAbs recognize multiple glycoproteins from
he HHV-8-infected BCBL-1 cells
To identify the HHV-8 proteins recognized by the anti-
8.1A/B MAbs, we used the uninduced and TPA-induced
ells in radioimmunoprecipitation (RIP) and Western blot
eactions. The K8.1A/B MAb 4A4 did not react with the
PA-induced 35S-methionine/cysteine-labeled uninfected
FIG. 2. Immunofluorescence reactivities of K8.1 A/B and K8.1A MAbs
8.1B proteins. (A and B) Reactivities of MAbs with BCBL-1 cells. Cells
f K8.1A/B MAb 4A4 with the acetone-fixed BCBL-1 cells. (B) Reactivit
ara-formaldehyde. (C–F) Reactivities of MAbs with COS-1 cells expres
cetone-fixed COS-1 K8.1A cells. (D) Reactivities of K8.1A/B MAb 4A4 wi
8.1A and K8.1B cells fixed with para-formaldehyde. (E) Reactivities of K
ith the COS-1 K8.1B cells.JAB cells (Fig. 3a, lane 1). In contrast, it recognized Beveral 35S-labeled polypeptides of about 28–72 kDa
rom TPA-induced BCBL-1 cells (Fig. 3a, lane 3). Longer
xposure of the autoradiographs also showed reactivi-
ies with similar molecular weight polypeptides from the
ninduced BCBL-1 cells (Fig. 3a, lane 2), suggesting the
eactivity with proteins from BCBL-1 cells entering lytic
ycles spontaneously. No reactivity was seen with the
3H-glucosamine-labeled TPA-induced BJAB cells (Fig. 3b,
ane 1). In contrast, several 3H-glucosamine-labeled gly-
opolypeptides of about 28–72 kDa were recognized by
he K8.1A/B MAbs from the TPA-induced BCBL-1 cells
Fig. 3b, lane 1). Similar size multiple polypeptides were
ecognized by the K8.1A MAbs (data not shown).
Immunoprecipitation of multiple glycoproteins by the
8.1A/B MAbs could be due to the reactivity with
olypeptides exhibiting a precursor and product relation-
hip sharing common antigenic epitopes or due to the
recipitation of polypeptides in a complex not sharing
ntigenic epitopes. To determine the identity of the var-
ous polypeptides precipitated by the MAbs, uninduced
nd TPA-induced (24–96 h postinduction) BCBL-1 and
V-8-carrying BCBL-1 cells and with COS-1 cells expressing K8.1A and
imulated with 20 ng/ml TPA and collected after 5 days. (A) Reactivities
K8.1A/B MAb 4A4 in the surface IFA with the BCBL-1 cells fixed with
e K8.1A and K8.1B proteins. (C) Reactivities of K8.1A MAb 2A3 with the
cetone-fixed COS-1 K8.1B cells. (E and F) Surface IFAs with the COS-1
Ab 2A3 with the COS-1 K8.1A cells. (F) Reactivities of K8.1A/B MAb 4A4with HH
were st
ies of
sing th
th the a
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241HHV-8 VIRION ENVELOPE GLYCOPROTEINS K8.1A/Bater. Samples were adjusted to equal protein concen-
rations and boiled in the sample buffer. About 10 mg of
ach protein was loaded per lane and tested in the
estern blot reactions; Figs. 3c and 3d show the reac-
ivity with adjacent lanes in the same gel. The K8.1A/B
Abs recognized a number of proteins with the molec-
lar weights ranging from about 28 to 72 kDa from the
PA-induced BCBL-1 cells (Fig. 3c, lane 3). A weak reac-
ion was seen with similar size proteins from the unin-
uced BCBL-1 cells (Fig. 3c, lane 2) but not with the BJAB
ells (Fig. 3c, lane 1). Because equal protein quantities
ere tested, the increased reactivities with TPA-induced
ells further support the IFA data (Fig. 2A) that MAbs
ecognized the lytic cycle K8.1A/B proteins induced by
PA. Reactivity with uninduced cells suggests the reac-
ivity with proteins from BCBL-1 cells spontaneously en-
ering lytic cycles. These results suggested that the mul-
iple proteins recognized by the MAbs in the RIP and
estern blot reaction were due to the reactivity with the
arious forms of K8.1A/B glycoproteins in the BCBL-1
ells such as the underglycosylated precursors, glyco-
ylated intermediates, and the final mature glycosylated
FIG. 3. Reactivities of the K8.1A/B MAbs with the HHV-8-infected an
) RIP reactions. Samples were analyzed on 12% acrylamide gel. Molecu
he molecular masses in kDa. Arrows indicate the HHV-8-specific prot
he RIP reactions with cells labeled with 35S-methionine/cysteine. Lan
ost-TPA induction. Lane 2, uninduced BCBL-1 cells labeled between
ost-TPA induction. (b) Reactivities of K8.1A/B MAb 4A4 in the RIP
HV-8-negative BJAB cells. Lane 2, BCBL-1 cells labeled between 72 a
he arrows indicate the HHV-8-specific glycoproteins immunoprecipita
amples were adjusted to equal protein concentrations and boiled in t
eactivity with adjacent lanes in the same gel was shown. (c) Reactivit
, uninduced BCBL-1 cells. Lane 3, BCBL-1 cells induced with TPA for 96
f K8.1A/B MAb 4A4. Lanes 5–8, reactivities of K8.1A MAb 4D6. Lanes 9–
3 protein. Lanes 1 and 5, uninduced BCBL-1 cells. Lanes 2, 6, and 9, BC
ith TPA for 48 h. Lanes 4, 8, and 11, BCBL-1 cells induced with TPAroducts sharing common antigenic epitopes. rytic expression of K8.1A/B glycoproteins
Our previous studies demonstrated that the K8.1A/B
ranscript is a late gene transcript (Chandran et al.,
998b). To examine the kinetics of K8.1A/B protein syn-
hesis, BCBL-1 cells were stimulated with TPA for 24, 48,
nd 96 h, and equal quantities of proteins were tested in
he Western blot reactions with the K8.1A and K8.1A/B
Abs. Rabbit antibodies against the HHV-8 latency-as-
ociated ORF 73 protein (V. Puri et al., manuscript in
reparation) was used as a control. Only weak reactivi-
ies with K8.1A and K8.1A/B MAbs were detected with the
ninduced and 24-h TPA-induced cells (Fig. 3d, lanes 1,
, 5, and 6). These MAbs recognized increasing quanti-
ies of the K8.1A/B glycoproteins from the BCBL-1 cells
nduced with TPA for 48 and 96 h (Fig. 3d, lanes 3, 4, 7,
nd 8). In general, the K8.1A/B MAbs (Fig. 3d, lanes 1–4)
eacted more strongly than the K8.1A MAbs (Fig. 3d,
anes 5–8). In contrast, the synthesis of the HHV-8 laten-
y-associated ORF 73 protein was constant during the
4- to 96-h TPA induction, and there was no change in
he kinetics of the multiple forms of ORF 73 proteins
cted cells in immunoprecipitation and Western blot reactions. (a and
ght markers were run in parallel lanes; the numbers on the left indicate
munoprecipitated by the MAb. (a) Reactivities of K8.1A/B MAb 4A4 in
A-induced HHV-8-negative BJAB cells labeled between 72 and 96 h
4 h. Lane 3, TPA-induced BCBL-1 cells labeled between 72 and 96 h
ions with cells labeled with 3H-glucosamine. Lane 1, TPA-induced
post-TPA induction. Samples were analyzed on 12% acrylamide gels.
the MAb. (c and d) Western blot reactivities with the total cell lysates.
ple buffer. About 10 mg of each protein was loaded per lane, and the
8.1A/B MAb 4A4. Lane 1, BJAB cells induced with TPA for 96 h. Lane
ples were analyzed on 12% acrylamide gels. (d) Lanes 1–4, reactivities
ctivities of rabbit antibodies against the HHV-8 latency-associated ORF
ells induced with TPA for 24 h. Lanes 3, 7, and 10, BCBL-1 cells induced
. Samples were analyzed on 12% acrylamide gels.d uninfe
lar wei
eins im
e 1, TP
0 and 2
react
nd 96 h
ted by
he sam
ies of K
h. Sam
11, rea
BL-1 cecognized (Fig. 3e, lanes 9–11). These results confirmed
t
u
t
V
t
m
w
K
g
w
t
s
B
w
i
i
(
l
n
o
T
t
m
f
p
e
d
o
w
s
s
p
w
M
e
w
g
e
g
R
o
N
d on enve
242 ZHU, PURI, AND CHANDRANhat the K8.1A/B glycoproteins are late lytic gene prod-
cts whose expression is stimulated greatly by the TPA
reatment.
irion-associated forms of K8.1A/B glycoproteins
To confirm the localization of K8.1A/B glycoproteins on
he surfaces of infected BCBL-1 cells, immune electron
icroscopy was done. Unfixed BCBL-1 cells stimulated
ith TPA for 24 or 92 h were incubated with K8.1A and
8.1A/B MAbs followed by anti-mouse antibodies conju-
ated with 10-nm gold particles. These cells were fixed
ith glutaraldehyde and embedded in resins; thin sec-
ions were made and observed under an electron micro-
cope. No reactivity was observed with TPA-induced
JAB cells (data not shown). In contrast, gold particles
ere detected on the surfaces of about 10–15% of TPA-
nduced BCBL-1 cells (Figs. 4A and 4B). MAbs recogniz-
ng the K8.1A protein (Fig. 4A) or the K8.1A/B proteins
FIG. 4. Reactivities of K8.1A/B and K8.1A MAbs with the surfaces of T
lectron microscopy assay. Cells were stimulated with 20 ng/ml TPA, co
ith 106 cells for 30 min at 37°C, washed five times, and incubated for
old particles. The cells were washed five times, fixed with 2% glutar
xamined. (A) Reactivities of K8.1A MAb 2A3. with BCBL-1 cells after 2
old particles on the surface of BCBL-1 cells with gold particles. La
eactivities of K8.1A/B MAb 4A4 with BCBL-1 cells after 2 days post-TP
n the surface of BCBL-1 cells with gold particles. (C) Reactivities of HH
o gold particles were detected on the virion envelopes. Magnification
ays post-TPA induction. Arrows indicate the gold particles on the viriFig. 4B) showed similar reactivities. A majority of the aatently infected BCBL-1 cells (Fig. 4A, large arrow) were
egative, demonstrating the specificity of the MAbs rec-
gnizing the lytic cycle-associated K8.1A/B proteins.
hese results confirmed the presence of K8.1A/B pro-
eins on the infected BCBL-1 cell membranes.
Examination of the cell surfaces by immune electron
icroscopy after 24 h post-TPA induction revealed only a
ew virus particles (data not shown), and more virus
articles were detected after 92-h TPA induction. How-
ver, the architecture of cells at 92 h was considerably
eteriorated. Despite this, gold particles were detected
n the surfaces of virion particles in samples incubated
ith the K8.1A/B (Fig. 4D) and K8.1A MAbs (data not
hown). These virus particles were found on the external
urfaces of the plasma membranes. Overall, more gold
articles were detected with the anti-K8.1A/B MAbs than
ith the anti-K8.1A MAbs. No reactivity was seen with
Ab 11D1 recognizing the HHV-8 early non-envelope-
ced BCBL-1 cells and with the HHV-8 virion envelopes in the immune
, and fixed with para-formaldehyde. Dilutions of MAbs were incubated
at 37°C with goat anti-mouse IgG antibodies conjugated with 10-nm
de, and embedded in resins. Thin sections were made, stained, and
ost-TPA induction. Magnification, 66,0003. Small arrows indicate the
ow indicates the cells not expressing the K8.1A/B glycoproteins. (B)
tion. Magnification, 82,0003. Small arrows indicate the gold particles
F 59 MAb 11D1 with the BCBL-1 cells after 4 days post-TPA induction.
03. (D) Reactivities of K8.1A/B MAb 4A4 with the BCBL-1 cells after 4
lopes. Magnification, 82,0003.PA-indu
llected
30 min
aldehy
days p
rge arr
A induc
V-8 OR
, 82,00ssociated ORF 59 protein (Fig. 4D) These results dem-
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243HHV-8 VIRION ENVELOPE GLYCOPROTEINS K8.1A/Bnstrated that the MAbs recognized the virion envelope-
ssociated K8.1A/B glycoproteins.
The virion envelopes of herpesviruses contain the fully
lycosylated final product of the glycoproteins (Kieff,
996; Spear, 1993). To determine which of the multiple
pecies of HHV-8 K8.1A/B glycoproteins detected in the
nfected cells (Figs. 3a–3d) were incorporated in the
irion envelopes, HHV-8 particles from TPA-induced KS-1
ells purified by two cycles of density gradient centrifu-
ation (Chatlynne et al., 1998) were solubilized with sam-
le buffer with and without 2-mercaptoethanol and
ested with the MAbs in the Western blot reactions. The
equence of KS-1 virus K8.1 gene amplified by PCR was
dentical to the sequences of BCBL-1 virus DNA (data not
hown). In contrast to the multiple proteins seen in the
PA-induced BCBL-1 cells, the K8.1A/B MAb 4A4 (Fig. 5a,
ane 1) and the K8.1A MAb 2A3 (Fig. 5a, lane 3) recog-
ized the virion particle-associated broad protein band of
8–72 kDa. The migration of these proteins remained
nchanged in the absence of 2-mercaptoethanol (Fig. 5a,
ane 2), suggesting the lack of disulfide linkages be-
ween the virion-associated K8.1A/B proteins. The lower-
olecular-weight bands detected in the infected cells
Figs. 3a–3d) were clearly absent in the virus particles.
his suggested that the virion-associated 68–72 kDa
roteins probably were the fully glycosylated mature
FIG. 5. Reactivities of K8.1A/B MAbs with the purified HHV-8 in the W
he Western blot reactions with the gradient-purified HHV-8 in sample b
8.1A MAb 2A3 with the HHV-8 in sample buffer with 2-mercaptoethano
ere run in parallel lanes; the numbers on the left indicate the molecu
Abs. (b) Reactivities of K8.1A/B MAb 4A4 in the Western blot reactions
irions. Lane 2, virions treated with neuraminidase (NU) and O-glycosid
ith neuraminidase (NU), O-glycosidase (O), and N-glyconase (N). Sam
un in parallel lanes; the numbers on the right indicate the molecular we
urified from the TPA-induced BCBL-1 cells. Lane 1, untreated affini
-glyconase (N). Samples were analyzed on 8–16% gradient acrylamid
he right indicate the molecular masses in kDa.orm of K8.1A/B proteins, and the reactivity of K8.1A MAb phowed that the virion particles predominantly contain
he K8.1A protein.
8.1A and K8.1 B glycoproteins contain both N- and
-linked sugars
To determine whether the virion-associated 68–72 kDa
8.1A/B glycoproteins represent the mature form of
8.1A/B proteins, virus particles were denatured, treated
ith glycosidase enzymes, Western blotted, and reacted
ith the K8.1A/B MAb 4A4. As a control, HHV-8 particles
ere also incubated at 37°C for 24 h without any en-
ymes. Under this condition, in addition to the prominent
8–72 kDa region, slightly smaller bands were also de-
ected (Fig. 5b, lane 1), probably due to proteolytic break-
own. In contrast, after digestion with the neuramina-
ase and O-glyconase, which removed only the O-linked
ugars (Fig. 5b, lane 2), or with the N-glyconase remov-
ng only the N-linked sugars (Fig. 5b, lane 3), the 68–72
Da band (Fig. 5b, lane 1) disappeared; instead, lower-
olecular-weight bands of about 54–46 kDa appeared.
owever, when the virus was incubated with all three
nzymes, the higher-molecular-weight bands disap-
eared, and the low-molecular-weight bands of about
6–34 kDa appeared (Fig. 5b, lane 4). These results
emonstrated that the K8.1A/B glycoproteins contain
oth N- and O-linked sugars, suggesting that the multiple
blot reactions. (a) Lanes 1 and 2, reactivities of K8.1A/B MAb 4A4 in
ith and without 2-mercaptoethanol, respectively. Lane 3, reactivities of
les were analyzed on 12% acrylamide gels. Molecular weight markers
sses (kDa) of the HHV-8 virion-associated proteins recognized by the
e gradient-purified HHV-8 treated with glycosidases. Lane 1, untreated
. Lane 3, virions treated with N-glyconase (1N). Lane 4, virions treated
ere analyzed on 12% acrylamide gels. Molecular weight markers were
kDa. (c) Reactivities of K8.1A/B MAb 4A4 with the K8.1A proteins affinity
ed K8.1A protein. Lane 2, affinity-purified K8.1A protein treated with
Molecular weight markers were run in parallel lanes; the numbers onestern
uffer w
l. Samp
lar ma
with th
ase (O)
ples w
ights in
ty-purifi
e gels.roteins recognized by the MAbs represent the precur-
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244 ZHU, PURI, AND CHANDRANor and product forms of K8.1A/B proteins and the 68–72
Da proteins represent the virion particle-associated ma-
ure form of these glycoproteins.
To characterize the infected cell-associated K8.1A/B
lycoproteins, TPA-induced BCBL-1 cell lysate was
assed over Sepharose 4B covalently coupled with
8.1A-specific 4D6 MAb and the flowthrough was passed
ver Sepharose 4B covalently coupled with K8.1A/B-spe-
ific 4A4 MAb. The unbound proteins were removed, and
he bound proteins were eluted and tested in the West-
rn blot reactions with K8.1A/B- or K8.1A-specific MAbs.
he profiles of protein eluted from the 4D6 (K8.1A) col-
mn or 4A4 (K8.1A/B) columns and the proteins recog-
ized by the K8.1A and K8.1A/B MAbs were identical. The
8.1A protein affinity-purified from the BCBL-1 cells ex-
ibited multiple forms with an intense band of about 36
Da and diffused bands of 40 to 72 kDa high-molecular-
eight glycoproteins (Fig. 5c, lane 1). There were no
ow-molecular-weight bands at 23 kDa corresponding to
he predicted precursor form of the K8.1B protein. After
-glyconase treatment, the 36-kDa band disappeared
nd a 26-kDa band appeared (Fig. 5c, lane 2, 1N). The
ntensity of the bands in the 40–70 kDa region was
educed but not eliminated. The predicted molecular
eight of the unglycosylated K8.1A protein is about 25
Da, which will be reduced to about 22 kDa after the
leavage of the predicted signal peptide (amino acids
–28) (Chandran et al., 1998b). After the N-glyconase
reatment, one molecule of N-acetyl glucosamine is still
ttached to the asparagine residue of the glycoprotein.
he protein bands detected in the 26 kDa region after the
-glyconase treatment (Fig. 5c, lane 2) could represent
he precursor forms of K8.1A protein, and the higher-
olecular-weight protein bands in the 40–72 kDa region
Fig. 5c, lane 2) could represent the K8.1A proteins con-
aining O-linked sugars without N-linked sugars due to
-glyconase treatment. These results further suggested
hat the K8.1A glycoprotein contains both N- and O-linked
ugars.
To characterize these proteins further, K8.1A and K8.1B
roteins were purified independently from the COS-1
ells by MAb affinity columns. Equal amounts of the
urified proteins were treated with glycosidic enzymes to
emove only the N-linked sugars, and the Western blot-
ed proteins were reacted with the K8.1A/B-specific MAb
A4. From the untreated COS-1-K8.1A protein sample, a
umber of proteins with molecular weights ranging from
bout 26 to 72 kDa were recognized (Fig. 6a, lane 1). In
ontrast, after N-glyconase treatment, MAb recognized
he lower-molecular-weight proteins ranging from 26 to
0 kDa (Fig. 6a, lane 2), indicating the presence of N-
inked sugars in the COS-1-K8.1A proteins. The protein
ands detected in the 26 kDa region after the N-glyco-
ase treatment (Fig. 6a, lane 2) could represent the
recursor forms of K8.1A protein, and the higher-molec-
lar-weight protein bands in the 43–62 kDa region (Fig. ma, lane 2) could represent the K8.1A proteins containing
-linked sugars without N-linked sugars due to N-glyco-
ase treatment. These results further strengthened the
otion that the HHV-8 K8.1A glycoprotein contains both
- and O-linked sugars.
The K8.1B protein purified from the COS-1 cells also
ppeared as multiple species of highly diffused protein
ands ranging from 23 to 72 kDa (Figs. 6b, lane 1, and 6c,
ane 1). After N-glyconase treatment, the 23-kDa band
isappeared and diffused bands at 16–18 kDa appeared
Figs. 6b, lane 2, and 6c, lane 2). The predicted molecular
eight of unglycosylated K8.1 B protein is about 18 kDa,
hich will be reduced to about 16 kDa after the cleavage
f the predicted signal peptide (amino acids 1–28). The
istinct protein band detected in the 18 kDa region after
he N-glyconase treatment (Figs. 6b and 6c, lane 2)
uggests that these could represent the precursor forms
f K8.1B protein, and the higher-molecular-weight protein
ands in the 40 to 62 kDa (Figs. 6b and 6c, lane 2) region
ould represent the K8.1B protein containing O-linked
ugars lacking N-linked sugars due to N-glyconase treat-
ent. These results suggested that K8.1B protein also
ontains both N- and O-linked sugars. The treatment of
OS1- K8.1B protein with neuraminidase followed by
-glycosidase and N-glyconase resulted in the disap-
earance of most of the high-molecular-weight bands
ith an increase in the intensity of the 16–18 kDa band
Fig. 6c, lane 3). These results suggested that K8.1B
lycoprotein also contains both N- and O-linked sugars.
DISCUSSION
In this study, we developed MAbs against HHV-8
8.1A/B glycoproteins and identified and characterized
he infected cells and the virion envelope-associated
orms of these glycoproteins. While these studies were
ompleted, using rabbit antibodies against the genomic
RF K8.1 protein (amino acids 26–142), Li et al. (1999)
eported that the K8.1 protein is a virion envelope-asso-
iated glycoprotein. However, the identity of the K8.1
rotein in the infected cells and virions was not defined.
n the COS-1 cells expressing the K8.1A cDNA, Li et al.
1999) identified a 37-kDa protein as a major species, a
7-kDa as a minor species, and 60–75 kDa proteins. In
he presence of tunicamycin, the 37-kDa and 60–75 kDa
roteins disappeared, and the 27-kDa protein band was
he major band detected. Our studies with TPA-induced
CBL-1 cells, COS-1 cells expressing K8.1A and B pro-
eins, and the purified virions show that the K8.1A and B
roteins undergo extensive post-translational modifica-
ion. Our studies also demonstrate that the 60–75 kDa
orms identified by us and Li et al. (1999) represent the
ature form of K8.1A/B glycoproteins containing both N-
nd O-linked sugars.
Our previous in vitro transcription/translation experi-
ents (Chandran et al., 1998b) and the treatments with
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245HHV-8 VIRION ENVELOPE GLYCOPROTEINS K8.1A/Blycosidases show the precursor–products relationship
etween the low- and higher-molecular-weight K8.1A and
proteins. Attempts to perform pulse-chase experiments
ere not successful, yet the levels of newly synthesized
8.1A/B proteins available for labeling were low due to
he low percentage (20%) of BCBL-1 cells expressing
iral proteins after 72–96 h post-TPA induction and due to
ontinuous cellular death. The better detection of
8.1A/B proteins in the Western blot reactions could be
ue to the quantitative accumulation of these proteins
uring TPA induction despite the degeneration of cells.
ecause the K8.1B protein is identical to the K8.1A pro-
ein except for the absence of 61 amino acids deleted by
he in-frame deletion of the transcript (Chandran et al.,
998b), the production of specific antibodies against the
8.1B protein was not possible. Moreover, the molecular
eights of the K8.1A and K8.1B proteins expressed inde-
endently in the COS-1 cells were closely similar. Hence,
FIG. 6. K8.1A and K8.1B proteins expressed in the COS-1 cells contain
nd B proteins affinity purified from the COS-1 K8.1A and K8.1B cells. To
8.1B proteins were passed over Sepharose 4B covalently coupled wit
luted with pH 2.5 buffer, and the bound K8.1B protein in the 4A4 colu
ith the K8.1A/B-specific MAb 4A4. Molecular weight markers were run
Da. (a) Lane 1, untreated affinity-purified K8.1A protein. Lane 2, affinit
ffinity-purified K8.1B protein. Lane 2, affinity-purified K8.1B protein trea
c) Lane 1, untreated affinity-purified K8.1B protein. Lane 2, affinity-purifi
rotein treated with neuraminidase (NU), O-glycosidase (O), and N-g
nalyzed on 8–16% gradient acrylamide gels.e were unable to determine the identity of the K8.1B srotein among the various glycoproteins recognized by
he K8.1A/B-specific proteins in the BCBL-1 cells and in
he virion envelopes. MAb affinity purification from the
CBL-1 cells demonstrates that the K8.1A glycoprotein is
he predominant species, and the reactivity of K8.1A MAb
howed that the virion particles contain predominantly
he K8.1A protein. Affinity purification of the gpK8.1A
lone also suggests the absence of complex formation
etween K8.1A and B proteins, which is similar to the
bsence of complex formation between the EBV enve-
ope glycoproteins gp350 and gp220.
Among the different glycoproteins encoded by the
HV-8, ORFs 8, 22, and 47 are homologous to the gly-
oproteins gB, gH, and gL, respectively, conserved
mong the other herpesviruses (Neipel et al., 1997;
usso et al., 1996). In contrast, comparison with the
uman or animal herpesvirus sequences to date show
hat the ORFs K8.1A and B are unique for HHV-8. This
- and O-linked sugars. Reactivities of K8.1A/B MAb 4A4 with the K8.1A
lysates from the stable COS-1 transformant cells expressing K8.1A and
MAb (K8.1A) or with 4A4 MAb (K8.1A/B). The bound K8.1A protein was
eluted with pH 11.5 buffer. Samples were tested in the immunoblots
allel lanes; the numbers on the right indicate the molecular masses in
d K8.1A protein treated with N-glyconase (1N). (b) Lane 1, untreated
h N-glyconase (1N). Samples were analyzed on 12% acrylamide gels.
B protein treated with N-glyconase (1N). Lane 3, affinity-purified K8.1B
e (N). HM-GPS, high-molecular-weight glycoproteins. Samples wereboth N
tal cell
h 4D6
mn was
in par
y-purifie
ted wit
ed K8.1
lyconasuggested that K8.1A/B glycoproteins may be mediating
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246 ZHU, PURI, AND CHANDRANmportant biological function or functions specific for
HV-8. The location of the HHV-8 ORF K8.1A gene in the
enome clearly suggests an important role of K8.1A and
proteins in the biology of HHV-8. The K8.1A gene is
ositionally colinear to the glycoprotein genes in the
embers of the gammaherpesvirus group such as the
BV gene encoding the major EBV glycoproteins gp350/
p220 (Kieff, 1996), gp150 gene of murine gammaherpes-
irus 68 (MHV68) (Rabb et al., 1998), herpesvirus saimiri
RF 51 gene (Russo et al., 1996), and the BORFD1 gene
f bovine herpesvirus-4 (BHV-4) (Rabb et al., 1998). Some
f these glycoproteins are involved in the binding of the
irus to the target cells; among these, the EBV gp350/
p220 has been studied extensively. HHV-8 gpK8.1A and
proteins show several similarities with the EBV glyco-
roteins. EBV gp350/gp220 elicits a strong humoral im-
une response (Kieff, 1996; Rickinson and Kieff, 1996),
nd our studies with human sera show that the HHV-8
8.1A and B are immunogenic proteins (Chandran et al.,
998b; Zhu et al., 1999). Similar to the specificity of our
Abs recognizing only the K8.1A protein or both K8.1A
nd B proteins, MAbs against gp350 reacts with gp350
nly or both gp350 and gp220 (Kieff, 1996), and there are
o gp220-specific MAbs. Like EBV gps, the gpK8.1A/Bs
re virion envelope- and infected cell membrane-associ-
ted glycoproteins. The EBV gp220 arises from an in-
rame deletion of gp350 transcripts and differs only in the
oss of 197 acids (Kieff, 1996; Tanner et al., 1987). The
8.1B arises from an in-frame deletion of the K8.1A tran-
cript (Chandran et al., 1998a,b). The nascent proteins of
p350 and gp220 are 135 and 100 kDa, respectively, and
he mature glycoproteins of about 350 and 220 kDa arise
y the addition of extensive N- and O-linked sugars (Kieff,
996). Similar to this, our studies show that the HHV-8
pK8.1A and B also are highly glycosylated molecules
ith the nascent proteins of 25 and 18 kDa, respectively,
ontaining both N- and O-linked sugars, and the HHV-8
irion-associated 68–72 kDa proteins represent the ma-
ure form of K8.1A and B glycoproteins.
The ability of anti-K8.1A/B MAbs to interfere in the
HV-8 infectivity must be evaluated. HHV-8 appears to
nfect a variety of cell lines of human and animal origin
ut does not establish a sustained productive infection
Renne et al., 1998; Vieira et al., 1997). Using an RT-PCR
ssay to amplify a spliced late HHV-8 mRNA transcript
ORF 29), Renne et al. (1998) showed that the human
idney cell line 293 transformed with adnovirus E1A
rotein can be infected with HHV-8 from BCBl-1 cells.
owever, this infection was inefficient, and the pattern of
iral gene expression does not represent an authentic
ytic infection. Infection can be detected only by the very
ensitive RT-PCR technique, suggesting that only a frac-
ion of the cells were infected. Eleven of 38 other cell
ines tested also supported HHV-8 infections that include
uman B cells, human endothelial cells, human lung
arcinoma cells, squamous cell carcinoma cells, owl (onkey kidney cells, and baby hamster kidney fibro-
lasts (BHK-21). All these in vitro infections were ex-
remely inefficient, and abortive (Renne et al., 1998; Vieira
t al., 1997). Recently, dermal microvascular endothelial
ells have been infected by HHV-8 from BCBl-1 in a very
imited fashion (Flore et al., 1998). Studies are in
rogress to test the ability of K8.1A and B MAbs to
eutralize the infection of the endothelial and 293 cells,
nd preliminary studies show that the K8.1A/B MAbs
revent HHV-8 binding to the target cells. MAbs against
p350/gp220 neutralize the EBV infectivity by preventing
he virus binding to the CD21 molecule. EBV gp350 and
p220 are the most abundant of the EBV glycoproteins
nd are responsible for attaching the virus to the com-
lement receptor CR2 or CD21 on B lymphocytes. HHV-8
ppears to have broader tropism than EBV because
HV-8 DNA and transcripts have been identified in hu-
an B cells (Cesarman et al., 1995; Schulz et al., 1998),
acrophages (Orenstein et al., 1997; Schulz et al., 1998),
nd endothelial cells (Boshoff et al., 1995; Staskus et al.,
997). HHV-8 has been shown to infect, albeit abortively,
wl monkey kidney cells and BHK-21 cells (Renne et al.,
998). Further studies are in progress to define the host
olecule or molecules recognized by the HHV-8 K8.1A
nd B glycoproteins.
MATERIALS AND METHODS
ell lines and virus
HHV-8-positive and EBV-negative BCBL-1 cells (Renne
t al., 1996) and HHV-8- and EBV-negative BJAB cells
ere grown in RPMI 1640 medium with glutaMAX I
GIBCO-BRL) supplemented with 10% heat-inactivated
BS and antibiotics. HHV-8 from TPA-induced KS-1 cells
urified by density gradient (Chatlynne et al., 1998) was
gift from Dr. D. V. Ablashi (ABI, Rockville, MD). The DNA
equence of KS-1 virus K8.1 gene amplified by PCR was
dentical to the sequences of BCBL-1 virus DNA.
abbit anti-peptide antibodies
To monitor the expression of K8.1A and B proteins,
nti-peptide antibodies were generated. The peptide
esignated K8.1A-CP (FSGSYSSGEPSRTTRIR) corre-
ponds to the carboxyl-terminus of K8.1A and B proteins
nd is absent in the genomic HHV-8 ORF K8.1. New
ealand White male rabbits were immunized with the
eptide, and the IgG antibodies (Ra 8.1A-CP) were puri-
ied from the sera by affinity chromatography on a protein
–Sepharose column (Pharmacia, Piscataway, NJ).
xpression of recombinant HHV-8 K8.1A/B proteins
n the baculovirus–insect cell system
A baculovirus GST expression and purification kit was
sed to prepare the recombinant HHV-8 proteinsPharMingen, San Diego, CA). The cDNAs encoding
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247HHV-8 VIRION ENVELOPE GLYCOPROTEINS K8.1A/BHV-8 ORFs K8.1A and K8.1B were previously identified
y screening a cDNA library from TPA-induced BCBL-1
DNA with serum from a patient positive for HIV and KS
Chandran et al., 1998a,b). The identified cDNAs were
eleased into the phagemid forms by in vivo excision
sing the ExAssist helper phage. The full-length cDNAs
f ORFs K8.1A and K8.1B were amplified by PCR with the
ollowing primers: K8.1A/B, 59-TTCCGCGTGAGCTCAT-
AGTTCCACACAGA-39 and 59-GGCCGGGTACCTTA-
ACTATGTAGG-39. The restriction sites in the primers
sed for cloning purposes are underlined. The PCR prod-
cts were cloned into the SacI and KpnI sites of the
AcGHLT-A baculovirus transfer vector and verified by
equence analyses. To generate the recombinant bacu-
ovirus, recombinant plasmids were cotransfected with
aculogold DNA (PharMingen) into Sf9 cells. Recombi-
ant virus was passaged three times before use. Expres-
ion and purification of fusion proteins were performed
ccording to the manufacturer’s recommendations
PharMingen).
roduction and characterization of MAbs against
HV-8 K8.1A and K8.1B glycoproteins
BCBL-1 cells were collected 4 days post-TPA induction
nd washed twice with PBS, and 1 3 107 cells were
njected per each Balb/c mouse intraperitoneally (Chan
t al., 1998). After two such injections, mice were
oosted subcutaneously with purified HHV-8 K8.1A and
8.1B proteins expressed in the baculovirus–insect cell
ystem. Mice were immunized with proteins mixed with
n equal amount of Freund’s adjuvant. Mice were bled by
ail vein, and dilutions of sera were tested in the Western
lot reaction with the K8.1A and B proteins. Spleen from
mouse with the highest level of antibodies was used
or fusion with Sp2/0.Ag14 myeloma cells (Balachandran
t al., 1982, 1989, 1992; Chan et al., 1998).
Hybridoma supernatants were screened by ELISA,
FA, and Western blot reactions. The IFA and ELISA using
ninduced and TPA-induced BCBL-1 and BJAB cells
ere done according to the procedures described pre-
iously (Chan et al., 1998; Chandran et al., 1998a,b). The
estern blot reactions with K8.1A, K8.1B, and GST pro-
eins expressed in the insect cells were performed ac-
ording to procedures described below. Clones secret-
ng antibodies reactive only with the BCBL-1 cells by IFA
nd ELISA and with the K8.1A/B proteins in the Western
lots were selected for further testing. These were fur-
her expanded, frozen, and single cell cloned twice.
onoclones were rescreened according to the same
echniques described above. Monoclonal culture super-
atants were used in an ELISA to determine the isotype
f antibodies (Pierce, Rockford, IL). High titer antibody
ontaining ascitic fluids were made by injecting hybrid-
ma cells intraperitoneally into Pristane-primed Balb/c
ice. IgGs were purified by protein A–Sepharose col- cmns and coupled with Sepharose 4B (Pharmacia) ac-
ording to the manufacturer’s recommendations.
estern blot assays
Uninduced and TPA-induced (24–96 h postinduction)
CBL-1 and BJAB cells were collected, washed, and lysed
n distilled water. Samples were adjusted to equal protein
oncentrations and boiled in the sample buffer. Equal
mounts of these total cell lysate proteins (about 10 mg/
ane) or the GST column-purified GST-K8.1A, GST-K8.1B, and
ST control proteins (about 500 ng/lane) were separated by
2% or 8–16% gradient SDS–PAGE and electrophoretically
ransferred onto nitrocellulose membranes. Standard
restained molecular weight markers (GIBCO-BRL) were
ncluded in the parallel lanes. The membranes were
oaked in blocking solution (10 mM Tris–HCl, pH 7.2, 150
M NaCl, 5% skim milk, 0.02% NaN3) at 4°C overnight, and
hen reacted with MAbs or rabbit anti-peptide antibodies for
h at room temperature. The membranes were washed
hree times with washing buffer (10 mM Tris–HCl, pH 7.2,
50 mM NaCl, 0.3% Tween 20) and incubated for 1 h with
lkaline phosphatase-conjugated goat anti-mouse IgG or
nti-rabbit IgG (KPL, Gaithersburg, MD). Bound enzyme-
abeled antibodies were detected by color reaction of alka-
ine phosphatase with nitroblue tetrazolium and 5-bromo-
-chloro-3-indolyphosphate substrates (Sigma Chemical
o., St. Louis, MO). The reactions were stopped by washing
he membranes in distilled water.
ixed cell IFA
IFA was performed according to procedures described
reviously (Chan et al., 1998; Chandran et al., 1998a; Smith
t al., 1997). Briefly, 107 BCBL-1 cells in 10 ml of medium
ere induced with 20 ng/ml TPA (Sigma Chemical Co.).
ninduced and TPA-induced BCBL-1 and BJAB cells or
ninduced COS-1 cells and COS-1 cells expressing K8.1A
nd K8.1B proteins were collected, washed in PBS (pH 7.4),
potted onto slides (5-mm inner diameters, 10 circles per
lide), air dried in a laminar flow hood under UV light, and
ixed with cold acetone for 10 min. Fixed cells were incu-
ated for 30 min at 37°C with hybridoma culture superna-
ant. After incubation, slides were washed rigorously in
BS. The slides were incubated further for 30 min at 37°C
ith a prestandardized dilution of fluorescein isothiocya-
ate (FITC)-conjugated goat anti-mouse IgG. After washing,
he slides were counterstained with 1:10,000 dilution of
vans blue (Sigma) for 5 min at room temperature, washed,
nd mounted with 50% (v/v) glycerol in PBS. Slides were
xamined under a fluorescence microscope.
urface IFA and immune electron microscopy
Uninduced and TPA-induced (2–5 days postinduction)
CBL-1 and BJAB cells or uninduced COS-1 cells and
OS-1 cells expressing K8.1A and K8.1B proteins were
7ollected and washed once with RPMI. Cells (10 ) were
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248 ZHU, PURI, AND CHANDRANdded with 10 ml of 0.1% para-formaldehyde in PBS, pH
.4, and centrifuged at 1000 rpm for 10 min. These cells
ere washed twice, and cell concentrations were ad-
usted to 106 cells/ml. Then 1 ml of cells in Eppendorf
ubes were centrifuged for 10 min at 125 g, and the
upernatant was discarded. Dilutions of antibodies (200
l) were added, mixed, and incubated for 30 min at 37°C.
he tubes were centrifuged at 400 g, and the superna-
ants were discarded. The cells were washed five times
ith RPM containing 0.1% Na azide and then incubated
or 30 min at 37°C with the prestandardized dilutions of
ITC-conjugated goat anti-mouse or anti-rabbit IgG anti-
odies or with goat anti-mouse or anti-rabbit IgG anti-
odies conjugated with 10-nm gold particles (B.B. Inter-
ational). The cells were washed five times as described
bove. Cell pellets incubated with FITC antibodies were
ounted onto a glass slide and examined under a fluo-
escence microscope. Cells incubated with gold-conju-
ated antibodies were fixed with 2% glutaraldehyde and
mbedded in resins. Thin sections were made, stained,
nd examined under an electron microscope (Balachan-
ran et al., 1992).
IP
Uninduced and TPA-induced (72–96 h postinduction)
ells (107) were labeled for 20 h with 250 mCi of 35S-
ethionine and cysteine (Tran35S label; specific activity,
177 Ci/mmol; ICN, Irvine, CA) or with 500 mci of 3H-
lucosamine (specific activity, 25 Ci/mmol; American Ra-
iolabeled Chemicals Inc., St. Louis, MO) in deficient
MEM (Sigma). Immunoprecipitation was carried out
ccording to procedures described previously (Bal-
chandran et al., 1982, 1989; Smith et al., 1997). Briefly,
ells were solubilized with RIPA buffer (0.05 M Tris–HCl,
H 7.5, 0.15 M NaCl, 1% sodium deoxycholate, 1% Triton
-100, 100 U of aprotinin/ml, 0.1 mM phenylmethylsulfo-
yl fluoride), sonicated, and centrifuged at 100,000 g for
h. Equal trichloroacetic acid precipitable counts (5 3
05 cpm) of cell lysates were mixed with 300 ml of
ybridoma culture supernatants and 100 ml of protein
–Sepharose beads (Pharmacia, Piscataway, NJ) and
ere kept rocking at 4°C for 2 h. The precipitates were
ashed, dissociated by boiling in sample buffer, and
nalyzed by SDS–PAGE in 12% acrylamide cross-linked
ith 0.28% N,N9-diallyltartardiamide (Sigma). Molecular
eight markers (Sigma) were electrophoresed in parallel
hannels. Gels were stained, destained, infused with 1
salicyclic acid, dried on filter paper, and placed in
ontact with XAR-5 film (Kodak, Rochester, NY) at 270°C
or fluorography.
xpression of recombinant HHV-8 K8.1A and K8.1B
roteins in COS-1 cells
Full-length K8.1A and B cDNA clones were inserted
nto the BamHI and XhoI sites of the eukaryotic expres- sion vector pTarget (Promega, Madison, WI) containing
he cytomegalovirus immediate-early promoter/en-
ancer. The COS-1 cells were transfected with 2 mg of
Target-K8.1A/B DNA using CLONfectin (Clontech) ac-
ording to the manufacturer’s protocols. The COS-K8.1A
r B transformants were identified by IFA and Western
lot reactions using K8.1A/B-specific monoclonal anti-
ody 4A4. To select the stable transformants, transfected
ells were incubated with G418 antibiotics (700 mg/ml) in
he growth medium. Once the stable transformants were
solated, they were maintained in the selective medium
ontaining 400 mg/ml active G418. Stable single-cell
lones of COS-K8.1A and COS-K8.1B were established
ubsequently.
urification of the recombinant HHV-8 K8.1A
nd B proteins
To purify the K8.1A and B proteins, TPA-induced
CBL-1 cells, COS-1 K8.1A, or COS K8.1B cells were
ysed on ice for 1 h with lysing buffer (10 mM Tris–Cl, pH
.0, 140 mM NaCl, 0.025% NaN3, 2% Triton X-100, 1%
a-DOC, 0.2 U/ml aprotinin, and 1 mM phenylmethylsul-
onyl fluoride). Cell lysates were first passed over Sepha-
ose 4B covalently coupled with K8.1A-specific MAb 4D6
t 4°C, and the flowthrough was passed over Sepharose
B covalently coupled with K8.1A/B-specific MAb 4A4.
he unbound proteins were removed by extensive wash-
ng with lysis buffer and monitored by checking the
bsorbance at 260/280 nm in a spectrophotometer. The
ound K8.1A protein was eluted with low pH buffer (50
M glycine–HCl, pH 2.5, in 150 mM NaCl and 0.1%
onidet P-40), and the bound K8.1B protein was eluted
ith high-pH elution buffer (50 mM triethanolamine, pH
1.5, in 150 mM NaCl and 0.1% Nonidet P-40) and imme-
iately neutralized with 1/10 volume of 1 M Tris–HCl, pH
.0 or 6.5. The peak fractions were pooled, dialyzed
gainst PBS, and stored at 270°C.
nzymatic treatments of K8.1A and B proteins
Affinity-purified glycoproteins (;5 mg) or the gradient-
urified HHV-8 was first denatured by boiling for 4 min in
he digestion buffer (50 mM sodium phosphate, pH 7.5,
0 mM EDTA, 20 mM NaN3, 0.1% SDS, 1% Nonidet P-40)
nd then treated with glycosidases (Balachandran and
utt-Fletcher, 1985). To remove N-linked sugars, proteins
ere incubated with 4 U of N-glycosidase F (Boehringer)
or 24 h at 37°C. To remove O-linked carbohydrates,
roteins were first incubated with 4 mU of neuramini-
ase (Boehringer) for 2 h at 37°C, followed by a 22-h
ncubation with 2.5 mU of O-glycosidase (Boehringer)
nd 4 U of N-glycosidase F. Equal amounts of digested
roteins were separated by SDS–PAGE, transferred onto
itrocellulose membranes, and reacted with K8.1A/B-
pecific MAb 4A4.
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